Biocon Biologics signed a distribution agreement with Sandoz, granting the company the exclusive rights to promote, sell and distribute Adalimumab BS for subcutaneous injection.
Biocon shares gain on immunity jab distribution deal with Sandoz for Japan on December 26, 2023 at 4:11 am
